Hanne Damgaard Jensen
Chief Operating Officer at CURASIGHT A/S
Net worth: 6 292 $ as of 2024-03-30
Network origin in Hanne Damgaard Jensen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
26
| Public Company | Pharmaceuticals: Major | 26 |
| Public Company | Medical Specialties | 9 | |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hanne Damgaard Jensen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TDC A/S | Major Telecommunications | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Director/Board Member Director/Board Member | |
International N&H Denmark ApS
 International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Food: Major Diversified | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| AP MOLLER MAERSK | Marine Shipping | Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Svenskt Näringsliv
 Svenskt Näringsliv Miscellaneous Commercial ServicesCommercial Services Svenskt Näringsliv provides consulting services. It focuses on protection, support, and promotion of the interests of businesses. The firm provides its members with knowledge in a number of areas including labor market and law, taxes, corporate law and intellectual property, economics and macro analysis, constitutional and legal protection, security and risk management, and trade policy. The company was founded on March 29, 2001 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Danfoss A/S
 Danfoss A/S Industrial MachineryProducer Manufacturing Danfoss A/S operates as an engineering company. The firm manufactures refrigeration, air conditioning, and industrial controls for several industries. Its products include thermostatic expansion valves, solenoid, pressure and temperature regulators, electronic controls, line components, electronically operated, coils, solenoid, pressure controls and thermostats, filter driers, sight glasses, contactors and motor starters, liquid level controls, condensing units, appliance, controls accessories and spare parts, compressors for air conditioning, heating and refrigeration, heat exchangers, and valve station. It operates through the following segments: Danfoss Power Solutions, Danfoss Climate Solutions, Danfoss Power Electronics and Drives, and Other Areas. The Danfoss Power Solutions segment establishes electric powertrain systems. The Danfoss Climate Solutions segment includes heating and cooling solutions for buildings, cold chains, industry, and infrastructure. The Danfoss Power Electronic and Drives segment focuses on the decarbonization with electric and energy solutions for vehicles and industry. The company was founded by Peter Johan Mads Clausen on September 1, 1933 and is headquartered in Nordborg, Denmark. | Industrial Machinery | Director/Board Member Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
EEP Advisers Ltd.
 EEP Advisers Ltd. Investment ManagersFinance EEP Advisers Ltd. (EEP) is a private equity firm founded in 1999 by Hans Blomberg and David Kauffmann. The firm is headquartered in London. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| ORSTED A/S | Electric Utilities | Corporate Officer/Principal Chief Executive Officer | |
| Princeton University | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Masters Business Admin | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| University of Aarhus | College/University | Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Founder | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Masters Business Admin Graduate Degree Graduate Degree Doctorate Degree | |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Investment Managers | Private Equity Investor Chief Executive Officer | |
| University of Lund | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Utrecht | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| International Institute for Management Development | College/University | Masters Business Admin Masters Business Admin | |
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
NNE A/S
 NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark. | Engineering & Construction | Director/Board Member Chairman | |
PricewaterhouseCoopers (Denmark)
 PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal President Director of Finance/CFO | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder Chief Executive Officer Founder Chief Executive Officer Corporate Officer/Principal | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Founder General Counsel Director/Board Member | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| NNIT A/S | Information Technology Services | Chairman Director/Board Member Corporate Officer/Principal | |
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Arts Biologics A/S | Director/Board Member Chief Executive Officer | ||
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Founder Director/Board Member | |
Ascendis Pharma Endocrinology Division A/S
 Ascendis Pharma Endocrinology Division A/S Pharmaceuticals: MajorHealth Technology Ascendis Pharma Endocrinology Division A/S engages in pharmaceutical preparations. The company was founded on June 29, 2012 and is headquartered in Hellerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Bactolife A/S
 Bactolife A/S BiotechnologyHealth Technology Bactolife A/S is a Danish industrial biotech company that specializes in developing biological solutions to strengthen the gut microbiome and combat antimicrobial resistance. Bactolife is based in Kongens Lyngby, Denmark and was founded in 2017 by Andreas Hougaard Laustsen, Per Falholt, Mads Laustsen, David Kauffmann, and Sandra Wingaard Thrane. The company has approximately 40 employees and uses its proprietary binding protein technology to select and produce binding proteins that act on toxins without targeting growth or killing bacteria directly. Bactolife is developing and marketing ingredients for various groups, including mothers and children, the elderly, immunodeficient individuals, travelers, deployed individuals, and animal health. The company has proof of concept for its technology, including its most advanced animal health product, ablacto+, which stabilizes the gut of piglets and reduces the severity of post-weaning diarrhea. Mads Laustsen has been the CEO since 2017. | Biotechnology | Founder Founder | |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Lactobio ApS | Director/Board Member Founder |
Statistics
International
| Denmark | 38 |
| United States | 6 |
| Sweden | 3 |
| Netherlands | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 9 |
| Finance | 5 |
| Commercial Services | 4 |
| Communications | 2 |
Operational
| Director/Board Member | 343 |
| Corporate Officer/Principal | 158 |
| Chairman | 142 |
| Independent Dir/Board Member | 84 |
| Chief Executive Officer | 66 |
Most connected contacts
| Insiders | |
|---|---|
| Peter James Arthur Benson | 58 |
| Henrik Poulsen | 37 |
| Bo Jesper Hansen | 34 |
| Jesper Brandgaard | 28 |
| Anker Gunvald Lundemose | 25 |
| Jens Jesper Ovesen | 25 |
| Bruce Carter | 25 |
| Martin Olin | 25 |
| Anna Héléne Barnekow | 24 |
| Anders Gersel Pedersen | 24 |
| Michael Wolff Jensen | 23 |
| Jan Ulf Sigvar J. Johansson | 23 |
| Burt Malkiel | 22 |
| Thomas Feldthus | 20 |
| Peter Nordkild | 20 |
- Stock Market
- Insiders
- Hanne Damgaard Jensen
- Company connections
